Cubist Systematic Strategies, LLC Xencor Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Xencor Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 68,029 shares of XNCR stock, worth $1.57 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

68,029

Previous 101,653 33.08%

Holding current value

$1.57 Million

Previous $1.92 Million 28.9%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.7 - $21.65 $527,896 - $727,959	-33,624 Reduced 33.08%	68,029 $1.37 Million
Q2 2024 Aug 14, 2024	SELL	$18.21 - $24.5 $1.67 Million - $2.25 Million	-91,691 Reduced 47.42%	101,653 $1.92 Million
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $1.05 Million - $1.49 Million	56,255 Added 41.04%	193,344 $4.28 Million
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $1.88 Million - $2.43 Million	113,533 Added 481.97%	137,089 $2.91 Million
Q3 2023 Nov 14, 2023	BUY	$20.08 - $25.39 $473,004 - $598,086	23,556 New	23,556 $474,000
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $228,836 - $284,868	9,231 New	9,231 $240,000
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $2.77 Million - $4.07 Million	140,198 Added 249.1%	196,479 $5.38 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $1.19 Million - $1.86 Million	44,567 Added 380.46%	56,281 $1.5 Million
Q4 2021 Feb 14, 2022	SELL	$33.67 - $43.44 $249,764 - $322,237	-7,418 Reduced 38.77%	11,714 $470,000
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $624,524 - $727,015	-20,376 Reduced 51.57%	19,132 $625,000
Q2 2021 Aug 16, 2021	BUY	$34.33 - $44.68 $620,961 - $808,171	18,088 Added 84.44%	39,508 $1.36 Million
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $55,583 - $73,384	1,362 Added 6.79%	21,420 $922,000
Q4 2020 Feb 16, 2021	SELL	$36.63 - $47.63 $620,585 - $806,947	-16,942 Reduced 45.79%	20,058 $875,000
Q3 2020 Nov 16, 2020	BUY	$30.09 - $43.02 $497,267 - $710,948	16,526 Added 80.72%	37,000 $1.44 Million
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $568,358 - $684,241	20,474 New	20,474 $663,000
Q1 2020 May 15, 2020	SELL	$20.69 - $37.79 $1.19 Million - $2.17 Million	-57,529 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$32.75 - $41.43 $1.55 Million - $1.97 Million	47,475 Added 472.2%	57,529 $1.98 Million
Q3 2019 Nov 14, 2019	BUY	$33.73 - $46.27 $339,121 - $465,198	10,054 New	10,054 $339,000
Q2 2019 Aug 14, 2019	SELL	$29.6 - $40.93 $95,371 - $131,876	-3,222 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$27.85 - $38.09 $89,732 - $122,725	3,222 New	3,222 $100,000
Q4 2018 Feb 14, 2019	SELL	$32.39 - $42.05 $199,781 - $259,364	-6,168 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$35.69 - $47.65 $220,135 - $293,905	6,168 New	6,168 $240,000
Q4 2017 Feb 14, 2018	SELL	$19.29 - $24.83 $15,567 - $20,037	-807 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$19.61 - $23.35 $15,825 - $18,843	807	807 $18,000

Others Institutions Holding XNCR

# of Institutions

215

Shares Held

71.8M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.38B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Xencor Inc Transaction History